Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 April, 2024 11:24 IST
Dr. Reddy's Lab launches Ezetimibe & Simvastatin tablets in US
Source: IRIS | 27 Apr, 2017, 11.05AM
Rating: NAN / 5 stars.
Comments  |  Post Comment

Dr. Reddy's Laboratories has launched Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg a therapeutic equivalent generic version of Vytorin (Ezetimibe and Simvastatin) Tablets in the United States market, approved by the U.S. Food and Drug Administration (USFDA). Dr. Reddy's is among the first companies to launch the generic product in the U.S. market.

The Vytorin brand had U.S. sales of approximately USD 678 million MAT for the most recent twelve months ended in February 2017 according to IMS Health. 

Dr. Reddy's Ezetimibe and Simvastatin Tablets are available in bottle count sizes of 30, 90 and 1000. Vytorin is a registered trademark of MSD International GmbH.

Shares of the company declined Rs 4.2, or 0.16%, to trade at Rs 2,606.85. The total volume of shares traded was 18,807 at the BSE (10.53 a.m., Thursday).

 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer